Pfizer

How generic cyclosporine might affect optometry
How generic cyclosporine might affect optometryI foresee every dry eye script I write to be “changed” to generic cyclosporine. This means optometrists will be straddled with more burdensome prior authorizations and delays for the patients.
FDA warns Pfizer’s Meridian over EpiPen flawsFDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
FDA Sends Warning Letter to EpiPen Manufacturer
FDA Sends Warning Letter to EpiPen ManufacturerEpiPen manufacturer is accused of lax investigation into problems.
New universal companion diagnostic paves the way for precision oncologyFDA approves new diagnostic test for non-small cell lung cancer.
Paliperidone and Clindamycin Recalls
Sodium Bicarbonate Injections RecalledThe recall is a major setback in the ongoing sodium bicarbonate shortage.
New treatments on the horizonEmerging therapies are showing impressive efficacy and good tolerability, according to one dermatologist.
Immuno-oncology bladder drug wins approvalSoon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
New abuse-deterrent opioid availableA new abuse-deterrent painkiller - oxycodone hydrochloride (RoxyBond, Inspirion Delivery Services) - will be available soon after receiving FDA approval.
New therapies show promise in treating diabetes
New therapies show promise in treating diabetesNew updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.